IDEXX Laboratories Inc
(LTS:0J8P)
$
449.1499
0.1499 (0.03%)
Market Cap: 36.85 Bil
Enterprise Value: 37.52 Bil
PE Ratio: 44.50
PB Ratio: 23.46
GF Score: 99/100 IDEXX Laboratories Inc at Bank of America Merrill Lynch Animal Health Summit Transcript
Feb 25, 2019 / 03:55PM GMT
Release Date Price:
$209.18
(-1.07%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
With us, we've got IDEXX Laboratories, and we're hosting Brian McKeon, CFO; and Jay Mazelsky, VP and Head of North American CAG business. So I want to thank you very much for coming in. Pleasure to have you as always.
Brian P. McKeon
IDEXX Laboratories, Inc. - CFO, Executive VP & Treasurer
Thanks, Mike.
Questions & Answers
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
I think we'll start with just a quick overview. I mean, can you recap 2018 for us? Do you have an eventful year, a lot of things going on? What do you see in the business? And sort of what's your view of the industry as we sit here today?
Brian P. McKeon
IDEXX Laboratories, Inc. - CFO, Executive VP & Treasurer
Yes, we had a -- thanks for having us here today, Mike. We, at IDEXX, had an excellent year in 2018. One of the key metrics we focus on is our companion animal diagnostics
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot